ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,601, issued on May 6, was assigned to Synthon B.V. (Nijmegen, Netherlands).
"Pharmaceutical composition comprising axitinib" was invented by Manuel Gago Guillan (Sant Boi de Llobregat, Spain), Rohit Kumar (Sant Boi de Llobregat, Spain) and Lisardo Alvarez Fernandez (Sant Boi de Llobregat, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an immediate release tablet composition comprising axitinib form IV characterized by an XRPD pattern comprising the peaks at about 8.9, 12.0, 14.6, 15.2, 15.7, 17.8, 19.1, 20.6, 21.6, 23.2, 24.2, 24.9, 26.1 and 27.5plus-minus0.1 degrees 2Theta, when measured with Cu KAlpha1 radiat...